Uterine Cancer Information Center
Each year in the United States, approximately 40,000 women are diagnosed with uterine cancer (also known as endometrial cancer). It is estimated that there are more than 572,000 uterine cancer survivors in the U.S. today.
In an effort to improve both survival and quality of life among women with uterine cancer, researchers have explored new approaches to surgery, radiation therapy, chemotherapy, and supportive care (care to manage cancer symptoms and treatment side effects).
Understanding uterine cancer treatment options, the role of different doctors specializing in the treatment of uterine cancer, and how and when to access new and innovative uterine cancer treatment options available through clinical trials is essential in order to achieve the best outcome from uterine cancer treatment.
The Cancer Consultants Uterine Cancer Information Center has been designed to help patients understand uterine cancer and uterine cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of uterine cancer.
Headline Uterine Cancer News 
Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Aspirin Continues to Look Promising for Cancer Prevention
Study reports fewer cases and fewer deaths with daily use.
Study Supports Laparoscopy for Uterine Cancer
Slightly higher recurrence rate, but similar overall survival and quicker recovery.
Uterine Cancer Tips
Men who confront a cancer diagnosis before beginning or completing their families...
Women who confront a cancer diagnosis before beginning or completing their families...
You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Uterine Cancer Management
Inspiration, Hope & Resources
Fran Drescher: Cancer Schmancer Actress, producer, and advocate Fran Drescher launches a movement created to change...
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Uterine Cancer Clinical Trials
GOG0209 – A Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF Versus Carboplatin/Paclitaxel in Patients with Stage III & IV or Recurrent Endometrial Cancer
GOG0238 – A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
GOG0248 – A Randomized Phase II Trial of Temsirolimus (NCI-Supplied Agent, NSC # 683864, IND # 61010) or the Combination of Hormonal Therapy Plus Temsirolimus in Women with Advanced, Persistent, or Recurrent Endometrial Carcinoma




